Skip to main content
Clinical Trials/NL-OMON55883
NL-OMON55883
Completed
Not Applicable

on-invasive measurement of mitochondrial function in vivo (NIMFO) in septic patients - NIMFO

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis, COVID-19
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Intensive care patients:
  • In order to be eligible to participate in this study, a subject must meet the
  • following criteria:
  • \* 18\-90 years of age
  • \* Admission to intensive care ward within 72 hours before inclusion
  • Aged and gender matched healthy controls:
  • \* 18\-90 years of age
  • \* No relevant comorbidities (ASA I/II)
  • \* Matched in age (±5 years) and gender to one of the participants in the
  • COVID\-19 group.

Exclusion Criteria

  • \* Mentally disabled
  • \* Porphyria
  • \* Presence of mitochondrial disease
  • Healthy controls group:
  • \* Presence of COVID\-19/sepsis related complains or symptoms
  • \* Presence of COVID\-19/sepsis symptoms or complains, or a positive COVID\-19
  • test less than one month ago
  • \* COVID\-19 vaccination less than two weeks ago

Outcomes

Primary Outcomes

Not specified

Similar Trials